文献速递神经免疫

HIV感染者中多发性硬化的风险:一项国际队列研究

Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.
PubMed 文献 · Ann Neurol · 2023-12-14

该国际队列研究基于瑞典和加拿大不列颠哥伦比亚省人群健康数据,比较HIV阳性者与一般人群的多发性硬化(MS)发病风险。合并队列纳入29163例HIV阳性者(75%为男性),随访242248人年,观察到14例MS,预期26.19例,标准化发病比(SIR)为0.53(95%CI=0.32-0.90);首次抗逆转录病毒治疗(ART)暴露后MS的SIR为0.55(95%CI=0.31-0.96)。研究显示HIV阳性者及ART暴露的HIV阳性者MS风险较低。

要点

  • HIV阳性人群MS的标准化发病比(SIR)为0.53(95%CI=0.32-0.90)。
  • 首次ART暴露后MS的SIR为0.55(95%CI=0.31-0.96)。
  • 研究结果支持进一步探索HIV、ART与MS之间的关系。

核心结论

  • 这项国际人群研究显示,HIV阳性个体及HIV阳性且ART暴露个体的MS风险较低。
  • 研究结果支持进一步探索HIV、ART与MS之间的关系。

研究设计与样本

  • 基于人群的队列研究,纳入瑞典和加拿大不列颠哥伦比亚省两个HIV阳性人群队列。
  • 合并队列共29163例HIV阳性者,其中75%为男性。
  • 随访自HIV首次临床证据后1年或完整行政健康数据首日起,至发生MS、移民、死亡或研究结束(加拿大2020年3月31日,瑞典2018年12月31日)中最早者。
  • 观察到的MS发病率与一般人群随机样本(每个一般人群的>20%)中按年龄、性别、日历年、收入和出生地区特异性的预期率进行比较。

主要发现

  • 随访期间共242248人年,HIV阳性队列中观察到14例新发MS,预期为26.19例。
  • HIV阳性人群MS的标准化发病比(SIR)为0.53(95%CI=0.32-0.90)。
  • 首次ART暴露后MS的SIR为0.55(95%CI=0.31-0.96)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There has been interest in a possible negative association between HIV and multiple sclerosis (MS). We aimed to compare the risk of MS in a cohort of individuals living with HIV to that in the general population. METHODS: Population-based health data were accessed for 2 cohorts of HIV-positive persons from Sweden and British Columbia, Canada. Incident MS was identified using MS registries or a validated algorithm applied to administrative data. Individuals with HIV were followed from 1 year after the first clinical evidence of HIV or the first date of complete administrative health data (Canada = April 1, 1992 and Sweden = January 1, 2001) until the earliest of incident MS, emigration, death, or study end (Canada = March 31, 2020 and Sweden = December 31, 2018). The observed MS incidence rate in the HIV-positive cohort was compared to the expected age-, sex-, calendar year-, income-specific, and region of birth-specific rates in a randomly selected sample of >20% of each general population. The standardized incidence ratio (SIR) for MS following the first antiretroviral therapy exposure ("ART-exposed") was also calculated. RESULTS: The combined Sweden-Canada cohort included 29,163 (75% men) HIV-positive persons. During 242,248 person-years of follow-up, 14 incident MS cases were observed in the HIV-positive cohort, whereas 26.19 cases were expected. The SIR for MS in the HIV-positive population was 0.53 (95% confidence interval [CI] = 0.32-0.90). The SIR for MS following the first ART exposure was 0.55 (95% CI = 0.31-0.96). INTERPRETATION: This international population-based study demonstrated a lower risk of MS among HIV-positive individuals, and HIV-positive ART-exposed individuals. These findings provide support for further exploration into the relationship among HIV, ART, and MS. ANN NEUROL 2024;95:487-494.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. McKay KA, Wijnands JMA, Manouchehrinia A, et al. Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study. Ann Neurol. 2023. PMID: 38098141. doi:10.1002/ana.26840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。